Tackling Influenza in High-Risk Populations: Early Diagnosis and Treatment is Crucial to Improve Outcomes

Program Overview

Most people recover from uncomplicated influenza, but influenza can cause complications that result in severe illness and death. Some patients are at higher risk of experiencing these complications. In this program, physicians specializing in family medicine, internal medicine, and emergency medicine discuss their clinical experience about managing patients who develop symptoms of influenza and are at high risk of complications. They also explain recent changes to national guidelines. A patient who developed symptoms of influenza and was at high risk of complications shares his experience with testing and treatment for influenza.

Credit Expired
CE Credit Expired
Expires: December 29, 2020

Target Audience

This activity is designed for clinicians who manage influenza in high-risk patients.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Demonstrate a thorough understanding of the possible presentations of influenza in high-risk individuals and identify patients likely to benefit from antiviral therapy
  • Differentiate between the available influenza antivirals on the basis of their efficacy and safety data from clinical trials
  • Develop individualized guideline-compliant antiviral treatment plans for high-risk patients to achieve optimal clinical outcomes

Activity Faculty


Sherif Mossad, MD, FACP, FIDSA, FAST (Chair)

Staff, Department of Infectious Diseases
Section of Transplant Infectious Diseases
Respiratory Institute & Transplant Center
Professor, Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, OH


Jack Perkins, MD

Associate Professor, Emergency and Internal Medicine
Virginia Tech Carilion School of Medicine
Assistant Residency Director
Virginia Tech Carilion Emergency Medicine Residency
Roanoke Memorial Hospital
Roanoke, VA


Richard K. Zimmerman, MD, MPH, FIDSA, FAAFP

Tenured Professor, Family Medicine and Clinical Epidemiology
University of Pittsburgh
Pittsburgh, PA

Supporter Statement

Provider Statement

Disclosure of Financial Relationships


Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources